PubRank

Jan Geliebter

Author PubWeight™ 19.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling and induces senescence in papillary thyroid carcinoma cells. Cell Cycle 2011 1.67
2 Metastatic phenotype is regulated by estrogen in thyroid cells. Thyroid 2010 1.28
3 Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer. PLoS One 2011 0.97
4 Inhibition of uPAR and uPA reduces invasion in papillary thyroid carcinoma cells. Laryngoscope 2010 0.96
5 Effect of linoleic acid on proliferation and gene expression in the breast cancer cell line T47D. Cancer Lett 2004 0.91
6 Aging-associated changes in gene expression in the ACI rat prostate: Implications for carcinogenesis. Prostate 2005 0.86
7 Estrogen activity as a preventive and therapeutic target in thyroid cancer. Biomed Pharmacother 2011 0.86
8 3,3'-diindolylmethane inhibits migration and invasion of human cancer cells through combined suppression of ERK and AKT pathways. Oncol Rep 2010 0.86
9 DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines. Biomedica 2007 0.84
10 Arachidonate 5 lipoxygenase expression in papillary thyroid carcinoma promotes invasion via MMP-9 induction. J Cell Biochem 2012 0.83
11 3,3'-diindolylmethane modulates estrogen metabolism in patients with thyroid proliferative disease: a pilot study. Thyroid 2011 0.81
12 Ex vivo derived primary melanoma cells: implications for immunotherapeutic vaccines. J Cancer 2013 0.80
13 Computational peptide dissection of Melan-a/MART-1 oncoprotein antigenicity. Peptides 2004 0.80
14 3,3'-Diindolylmethane, a cruciferous vegetable derived synthetic anti-proliferative compound in thyroid disease. Biochem Biophys Res Commun 2005 0.80
15 Disruption of mutated BRAF signaling modulates thyroid cancer phenotype. BMC Res Notes 2014 0.78
16 Reduced Cx43 gap junction plaque expression differentiates thyroid carcinomas from benign disease. Arch Otolaryngol Head Neck Surg 2011 0.78
17 Molecular target based combinational therapeutic approaches in thyroid cancer. J Transl Med 2012 0.77
18 Interaction of a Mycobacterium tuberculosis repetitive DNA sequence with eukaryotic proteins. Biochem Biophys Res Commun 2004 0.77
19 Estradiol-mediated tumor neo-vascularization. Oncol Lett 2011 0.76
20 Atypical fetal prostate development is associated with ipsilateral hypoplasia of the wolffian ducts in the ACI rat. Anat Rec (Hoboken) 2010 0.75
21 Chemokines: small, but powerful regulators of the immune system--potential anti-tumor targets and reagents. Cancer Invest 2002 0.75
22 The urokinase plasminogen activator system in metastatic papillary thyroid carcinoma: a potential therapeutic target. J Clin Endocrinol Metab 2011 0.75
23 Gene therapy in cancer: the missing point. J Exp Ther Oncol 2005 0.75
24 Microarray analysis of diet-induced alterations in gene expression in the ACI rat prostate. Eur J Cancer Prev 2002 0.75
25 Cancer prevention and therapy: strategies and problems. J Exp Ther Oncol 2003 0.75